Silo Pharma, Inc. — Director's Dealing 2015

Jan 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Point Capital, Inc. (PTCI)
CIK: 0001514183
Period of Report: 2015-01-01

Reporting Person: Parker Walter Van Eps (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-01	Stock option (right to buy)	$0.30	J	112500	Acquired	2020-01-01	common (112500)	Direct

Footnotes

F1: Represents the issuance of immediately exercisable stock options to non-employee directors of the Issuer.